JNJ
Price
$155.38
Change
-$2.37 (-1.50%)
Updated
Apr 23 closing price
Capitalization
380.22B
89 days until earnings call
PFE
Price
$22.39
Change
-$0.14 (-0.62%)
Updated
Apr 23 closing price
Capitalization
157.14B
5 days until earnings call
Ad is loading...

JNJ vs PFE

Header iconJNJ vs PFE Comparison
Open Charts JNJ vs PFEBanner chart's image
Johnson & Johnson
Price$155.38
Change-$2.37 (-1.50%)
Volume$9.1M
Capitalization380.22B
Pfizer
Price$22.39
Change-$0.14 (-0.62%)
Volume$50.78M
Capitalization157.14B
JNJ vs PFE Comparison Chart
Loading...
JNJ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PFE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
JNJ vs. PFE commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JNJ is a Hold and PFE is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (JNJ: $155.38 vs. PFE: $22.39)
Brand notoriety: JNJ and PFE are both notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: JNJ: 87% vs. PFE: 93%
Market capitalization -- JNJ: $380.22B vs. PFE: $157.14B
JNJ [@Pharmaceuticals: Major] is valued at $380.22B. PFE’s [@Pharmaceuticals: Major] market capitalization is $157.14B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

JNJ’s FA Score shows that 2 FA rating(s) are green whilePFE’s FA Score has 1 green FA rating(s).

  • JNJ’s FA Score: 2 green, 3 red.
  • PFE’s FA Score: 1 green, 4 red.
According to our system of comparison, JNJ is a better buy in the long-term than PFE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

JNJ’s TA Score shows that 5 TA indicator(s) are bullish while PFE’s TA Score has 6 bullish TA indicator(s).

  • JNJ’s TA Score: 5 bullish, 5 bearish.
  • PFE’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, PFE is a better buy in the short-term than JNJ.

Price Growth

JNJ (@Pharmaceuticals: Major) experienced а +0.96% price change this week, while PFE (@Pharmaceuticals: Major) price change was +1.59% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +2.80%. For the same industry, the average monthly price growth was -3.79%, and the average quarterly price growth was -8.94%.

Reported Earning Dates

JNJ is expected to report earnings on Jul 22, 2025.

PFE is expected to report earnings on Aug 05, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+2.80% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JNJ($380B) has a higher market cap than PFE($157B). PFE has higher P/E ratio than JNJ: PFE (74.92) vs JNJ (30.34). JNJ YTD gains are higher at: 8.300 vs. PFE (-14.210). JNJ has higher annual earnings (EBITDA): 23.3B vs. PFE (9.56B). JNJ has more cash in the bank: 22.9B vs. PFE (12.7B). JNJ has less debt than PFE: JNJ (29.3B) vs PFE (70.8B). JNJ has higher revenues than PFE: JNJ (85.2B) vs PFE (58.5B).
JNJPFEJNJ / PFE
Capitalization380B157B242%
EBITDA23.3B9.56B244%
Gain YTD8.300-14.210-58%
P/E Ratio30.3474.9241%
Revenue85.2B58.5B146%
Total Cash22.9B12.7B180%
Total Debt29.3B70.8B41%
FUNDAMENTALS RATINGS
JNJ vs PFE: Fundamental Ratings
JNJ
PFE
OUTLOOK RATING
1..100
666
VALUATION
overvalued / fair valued / undervalued
1..100
18
Undervalued
3
Undervalued
PROFIT vs RISK RATING
1..100
23100
SMR RATING
1..100
4572
PRICE GROWTH RATING
1..100
4963
P/E GROWTH RATING
1..100
6198
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PFE's Valuation (3) in the Pharmaceuticals Major industry is in the same range as JNJ (18). This means that PFE’s stock grew similarly to JNJ’s over the last 12 months.

JNJ's Profit vs Risk Rating (23) in the Pharmaceuticals Major industry is significantly better than the same rating for PFE (100). This means that JNJ’s stock grew significantly faster than PFE’s over the last 12 months.

JNJ's SMR Rating (45) in the Pharmaceuticals Major industry is in the same range as PFE (72). This means that JNJ’s stock grew similarly to PFE’s over the last 12 months.

JNJ's Price Growth Rating (49) in the Pharmaceuticals Major industry is in the same range as PFE (63). This means that JNJ’s stock grew similarly to PFE’s over the last 12 months.

JNJ's P/E Growth Rating (61) in the Pharmaceuticals Major industry is somewhat better than the same rating for PFE (98). This means that JNJ’s stock grew somewhat faster than PFE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
JNJPFE
RSI
ODDS (%)
Bullish Trend 1 day ago
49%
Bullish Trend 1 day ago
70%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
44%
Bullish Trend 1 day ago
45%
Momentum
ODDS (%)
Bullish Trend 1 day ago
43%
Bullish Trend 1 day ago
48%
MACD
ODDS (%)
Bullish Trend 1 day ago
39%
Bullish Trend 1 day ago
55%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
42%
Bearish Trend 1 day ago
63%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
42%
Bearish Trend 1 day ago
59%
Advances
ODDS (%)
Bullish Trend 7 days ago
40%
Bullish Trend 9 days ago
56%
Declines
ODDS (%)
Bearish Trend 16 days ago
42%
Bearish Trend 16 days ago
60%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
52%
Bullish Trend 1 day ago
61%
Aroon
ODDS (%)
Bearish Trend 1 day ago
32%
Bearish Trend 1 day ago
58%
View a ticker or compare two or three
Ad is loading...
JNJ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PFE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ABTS2.570.32
+14.22%
Abits Group Inc
GDYN13.690.61
+4.70%
Grid Dynamics Holdings
MMSI93.712.26
+2.47%
Merit Medical Systems
RLGT5.980.11
+1.87%
Radiant Logistics
HAL20.61-0.09
-0.43%
Halliburton Company